Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Roberts Bryke, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ahrendsen JT, Hsu N, Wolf Z, Bryke C, Varma H. Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature. J Neuropathol Exp Neurol. 2020 Jun 01; 79(6):618-625. PMID: 32357369.
    Citations:    
  2. Vidal B, Bryke C, Hsu N, Alterman R, Yeo AT, Charest A, Varma H. A high-grade glioma with SOS1 amplification. Clin Neuropathol. 2020 May/Jun; 39(3):126-134. PMID: 31841105.
    Citations:    
  3. Ono Y, Goldsmith JD, Hsu N, Bryke C, Varma H. Papillary haemangioma in the spinal canal of a patient with a germline 12p microdeletion. Histopathology. 2019 07; 75(1):151-153. PMID: 30883855.
    Citations:    
  4. Poluben L, Bryke CR, Hsu Y, Shumeiko O, Neumerzhitska L, Klimuk B, Rybchenko L, Klymenko S, Balk SP, Fraenkel PG. Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis. Exp Oncol. 2019 Mar; 41(1):53-56. PMID: 30932413.
    Citations:    
  5. Poluben L, Puligandla M, Neuberg D, Bryke CR, Hsu Y, Shumeiko O, Yuan X, Voznesensky O, Pihan G, Adam M, Fraenkel E, Rasnic R, Linial M, Klymenko S, Balk SP, Fraenkel PG. Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident. Am J Hematol. 2019 01; 94(1):62-73. PMID: 30295334.
    Citations:    Fields:    
  6. Kanagal-Shamanna R, Hodge JC, Tucker T, Shetty S, Yenamandra A, Dixon-McIver A, Bryke C, Huxley E, Lennon PA, Raca G, Xu X, Jeffries S, Quintero-Rivera F, Greipp PT, Slovak ML, Iqbal MA, Fang M. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms. Cancer Genet. 2018 12; 228-229:197-217. PMID: 30377088.
    Citations:    
  7. Xu X, Bryke C, Sukhanova M, Huxley E, Dash DP, Dixon-Mciver A, Fang M, Griepp PT, Hodge JC, Iqbal A, Jeffries S, Kanagal-Shamanna R, Quintero-Rivera F, Shetty S, Slovak ML, Yenamandra A, Lennon PA, Raca G. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group. Cancer Genet. 2018 12; 228-229:218-235. PMID: 30344013.
    Citations:    
  8. Asakrah SK, Bhargava P, Bryke CR. EBV-positive, HHV8-negative large B-cell lymphoma with an unusual germinotropic growth pattern in an immunocompetent patient. Clin Case Rep. 2018 Sep; 6(9):1818-1824. PMID: 30214771.
    Citations:    
  9. Politikos I, McMasters M, Bryke C, Avigan D, Boussiotis VA. Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor. Blood Adv. 2018 06 26; 2(12):1367-1370. PMID: 29898877.
    Citations:    
  10. Antonello ZA, Hsu N, Bhasin M, Roti G, Joshi M, Van Hummelen P, Ye E, Lo AS, Karumanchi SA, Bryke CR, Nucera C. Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E. Oncotarget. 2017 Oct 17; 8(49):84743-84760. PMID: 29156680.
    Citations: 1     Fields:    
  11. McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, Long Priel DA, Pittaluga S, Raffeld MA, Calvo KR, Maric I, Desmond R, Holmes KL, Kuhns DB, Balabanian K, Bachelerie F, Porcella SF, Malech HL, Murphy PM. Chromothriptic cure of WHIM syndrome. Cell. 2015 Feb 12; 160(4):686-699. PMID: 25662009.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  12. Chorzalska A, Salloum I, Shafqat H, Khan S, Marjon P, Treaba D, Schorl C, Morgan J, Bryke CR, Falanga V, Zhao TC, Reagan J, Winer E, Olszewski AJ, Al-Homsi AS, Kouttab N, Dubielecka PM. Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia. 2014 Nov; 28(11):2165-77. PMID: 24699303.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  13. Dai Z, Kelly JC, Meloni-Ehrig A, Slovak ML, Boles D, Christacos NC, Bryke CR, Schonberg SA, Otani-Rosa J, Pan Q, Ho AK, Sanders HR, Zhang ZJ, Jones D, Mowrey PN. Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas. Mol Cytogenet. 2012 Dec 03; 5(1):44. PMID: 23198868.
    Citations: 10     
  14. Thorson L, Bryke C, Rice G, Artzer A, Schilz C, Israel J, Huber S, Laffin J, Raca G. Clinical and molecular characterization of overlapping interstitial Xp21-p22 duplications in two unrelated individuals. Am J Med Genet A. 2010 Apr; 152A(4):904-15. PMID: 20358600.
    Citations: 6     Fields:    Translation:HumansCells
  15. Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors. Leuk Res. 2009 Aug; 33(8):1144-6. PMID: 19394693.
    Citations: 8     Fields:    Translation:Humans
  16. Zangwill SD, Brown MD, Bryke CR, Cava JR, Segura AD. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1. Congenit Heart Dis. 2006 Sep; 1(5):229-32. PMID: 18377530.
    Citations: 2     Fields:    Translation:Humans
  17. Lloyd AR, Ragosta KG, Bryke CR, Hoo JJ. Desbuquois syndrome in three sisters with significantly different lengths of survival. Am J Med Genet A. 2006 Jun 01; 140(11):1253-5. PMID: 16642505.
    Citations:    Fields:    Translation:Humans
  18. Bellus GA, Spector EB, Speiser PW, Weaver CA, Garber AT, Bryke CR, Israel J, Rosengren SS, Webster MK, Donoghue DJ, Francomano CA. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am J Hum Genet. 2000 Dec; 67(6):1411-21. PMID: 11055896.
    Citations: 32     Fields:    Translation:HumansCells
  19. Shohat M, Lachman R, Gruber HE, Hsia YE, Golbus MS, Witt DR, Bodell A, Bryke CR, Hogge WA, Rimoin DL. Desbuquois syndrome: clinical, radiographic, and morphologic characterization. Am J Med Genet. 1994 Aug 01; 52(1):9-18. PMID: 7977470.
    Citations: 5     Fields:    Translation:HumansCells
  20. Poed LB, Hochhauser L, Bryke C, Streeten BW, Sloan J. Proboscis lateralis with associated orbital cyst: detailed MR and CT imaging and correlative embryopathy. AJNR Am J Neuroradiol. 1992 Sep-Oct; 13(5):1471-6. PMID: 1414844.
    Citations:    Fields:    Translation:Humans
  21. Lindgren V, Bryke CR, Ozcelik T, Yang-Feng TL, Francke U. Phenotypic, cytogenetic, and molecular studies of three patients with constitutional deletions of chromosome 5 in the region of the gene for familial adenomatous polyposis. Am J Hum Genet. 1992 May; 50(5):988-97. PMID: 1315124.
    Citations: 14     Fields:    Translation:HumansCells
  22. Lindgren V, Chen CP, Bryke CR, Lichter P, Page DC, Yang-Feng TL. Cytogenetic and molecular characterization of marker chromosomes in patients with mosaic 45,X karyotypes. Hum Genet. 1992 Feb; 88(4):393-8. PMID: 1740316.
    Citations: 13     Fields:    Translation:HumansCells
  23. Bryke CR, Lindgren V, Fryburg JS, Yang-Feng TL. Novel isodicentric chromosome 18 in an abnormal infant with a mosaic karyotype [46,XY/46,XY,-18,+dic(18)(q12.2]). Am J Med Genet. 1990 Jun; 36(2):247-50. PMID: 2368814.
    Citations: 1     Fields:    Translation:HumansCells
  24. Bryke CR, Breg WR, Potluri VR, Yang-Feng TL. Duplication of euchromatin without phenotypic effects: a variant of chromosome 16. Am J Med Genet. 1990 May; 36(1):43-4. PMID: 2333906.
    Citations: 2     Fields:    Translation:HumansCells
  25. Bryke CR, Mahoney MJ, Yang-Feng TL. Antenatal diagnosis of 45,X/48,XYYY. Am J Med Genet. 1989 Oct; 34(2):207-10. PMID: 2816999.
    Citations:    Fields:    Translation:HumansCells
  26. Bryke CR, Tunnessen WW, Scully TJ, Oski FA. Pediatric residencies: differences between 1959/1960 and 1984/1985. Pediatrics. 1988 Nov; 82(5):752-5. PMID: 3186356.
    Citations:    Fields:    Translation:Humans
  27. Graziano SL, Cowan BY, Carney DN, Bryke CR, Mitter NS, Johnson BE, Mark GE, Planas AT, Catino JJ, Comis RL, et al. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. Cancer Res. 1987 Apr 15; 47(8):2148-55. PMID: 3030544.
    Citations: 3     Fields:    Translation:HumansCells
  28. Sondheimer JM, Slagle TA, Bryke CR, Hill RB. Solitary rectal ulcer syndrome in a teenaged boy. J Pediatr Gastroenterol Nutr. 1985 Oct; 4(5):835-8. PMID: 4045639.
    Citations: 4     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bryke's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (169)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.